Eur Rev Med Pharmacol Sci 2020; 24 (14): 7574-7574

DOI: 10.26355/eurrev_202007_22245

Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis

H.-L. Li, S. Liang, J.-H. Cui, G.-Y. Han

The 2nd Department of General Surgery, Hongqi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang, Heilongjiang, China.


Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis, by H.-L. Li, S. Liang, J.-H. Cui, G.-Y. Han, published in Eur Rev Med Pharmacol Sci 2018; 22 (1): 127-134–DOI: 10.26355/eurrev_201801_14109–PMID: 29364479” has been withdrawn.

The Publisher apologizes for any inconvenience this may cause.

Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis

Free PDF Download

To cite this article

H.-L. Li, S. Liang, J.-H. Cui, G.-Y. Han
Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 14
Pages: 7574-7574
DOI: 10.26355/eurrev_202007_22245